Department of Neuroscience, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA; Neuroscience Graduate Program, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Brain Immunology and Glia (BIG) Center, Washington University School of Medicine, St. Louis, MO 63110, USA.
Department of Neuroscience, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA; Neuroscience Graduate Program, Washington University School of Medicine, St. Louis, MO 63110, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Brain Immunology and Glia (BIG) Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110, USA.
Immunity. 2024 Jun 11;57(6):1394-1412.e8. doi: 10.1016/j.immuni.2024.05.005. Epub 2024 May 30.
Recent single-cell RNA sequencing studies have revealed distinct microglial states in development and disease. These include proliferative-region-associated microglia (PAMs) in developing white matter and disease-associated microglia (DAMs) prevalent in various neurodegenerative conditions. PAMs and DAMs share a similar core gene signature. However, the extent of the dynamism and plasticity of these microglial states, as well as their functional significance, remains elusive, partly due to the lack of specific tools. Here, we generated an inducible Cre driver line, Clec7a-CreER, that targets PAMs and DAMs in the brain parenchyma. Utilizing this tool, we profiled labeled cells during development and in several disease models, uncovering convergence and context-dependent differences in PAM and DAM gene expression. Through long-term tracking, we demonstrated microglial state plasticity. Lastly, we specifically depleted DAMs in demyelination, revealing their roles in disease recovery. Together, we provide a versatile genetic tool to characterize microglial states in CNS development and disease.
最近的单细胞 RNA 测序研究揭示了发育和疾病中独特的小胶质细胞状态。这些状态包括在发育中的白质中与增殖区域相关的小胶质细胞 (PAMs) 和在各种神经退行性疾病中普遍存在的疾病相关小胶质细胞 (DAMs)。PAMs 和 DAMs 具有相似的核心基因特征。然而,这些小胶质细胞状态的动态性和可塑性的程度及其功能意义仍然难以捉摸,部分原因是缺乏特异性工具。在这里,我们生成了一种可诱导的 Cre 驱动系,Clec7a-CreER,该驱动系靶向大脑实质中的 PAMs 和 DAMs。利用这个工具,我们在发育过程中和几种疾病模型中对标记细胞进行了分析,揭示了 PAM 和 DAM 基因表达的趋同和上下文依赖性差异。通过长期追踪,我们证明了小胶质细胞状态的可塑性。最后,我们在脱髓鞘中特异性耗尽 DAMs,揭示了它们在疾病恢复中的作用。总之,我们提供了一种通用的遗传工具来描述中枢神经系统发育和疾病中的小胶质细胞状态。